---
figid: PMC10384750__pharmaceuticals-16-01004-g004
pmcid: PMC10384750
image_filename: pharmaceuticals-16-01004-g004.jpg
figure_link: /pmc/articles/PMC10384750/figure/pharmaceuticals-16-01004-f004/
number: Figure 4
figure_title: ''
caption: (A) showing the chemical structure of Rapamycin. (B) showing the rapamycin-mTOR
  interaction; rapamycin selectively binds and allosterictively inhibits mTORC1 at
  (FK506-binding protein) FKBP12.
article_title: Exploring the mTOR Signalling Pathway and Its Inhibitory Scope in Cancer.
citation: Suhail Ahmad Mir, et al. Pharmaceuticals (Basel). 2023 Jul;16(7):1004.
year: '2023'

doi: 10.3390/ph16071004
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI

keywords:
- cancer
- regulation of mTOR signalling pathway
- mTORC1/2
- mTOR inhibitors
- rapamycin

---
